Matthew Gallagher launched Medvi, a GLP-1 telehealth company, from his Los Angeles home in September 2024. Fourteen months ...

Medvi's marketing has included seemingly fake doctors and prompted lawsuits.

We have questions. The post AI-Powered Drug Marketer Medvi Responds After Allegations About Fake Doctors and Patients ...

The New York Times ran a glowing profile of a company called Medvi that's using AI to sell GLP-1s. The truth is more ...

The New York Times ran a story on April 2, 2026 (1), about how AI helped Los Angeles-based Matthew Gallagher build a startup ...

Matthew Gallagher utilized artificial intelligence tools to establish Medvi, a telehealth startup, which is projected to generate $1.8 billion in sales this year.

"After this article was published, many readers noted that Medvi was facing legal and regulatory actions for its business ...

A startup founder used tools like ChatGPT and Claude to write code, run customer service, and scale a telehealth business.

AI enables ultra-lean, one-person companies replacing employees, transforming business structure, efficiency, and taxation ...

Telehealth Platform Offers Compounded GLP-1 Injections and Oral Tablets at $299/Month With No Contract as 100,000+ Patients Seek Affordable Semaglutide Access Heading Into New Year Weight Loss Season ...

As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with expanded FDA-recognized access pathways, emerging treatment formats, and enhanced ...